| Lisa M Spors-murphy, OT | |
|
298 Osloski Rd, Eureka, MT 59917-9058 | |
| (406) 297-3915 | |
| (406) 297-3364 |
| Full Name | Lisa M Spors-murphy |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapy |
| Experience | 23 Years |
| Location | 298 Osloski Rd, Eureka, Montana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255388229 | NPI | - | NPPES |
| 1255388229 | Medicaid | MT | |
| 1255388229 | Other | MT | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 844 (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kalispell Regional Medical Center Inc | 5294644381 | 354 |
News Archive
A new study published in the journal Nature Medicine on January 2020 suggests that Parkinson's disease developing before the age of 50 years could be due to an abnormality in certain brain cells that remains dormant until the age of onset of the disease. It also indicates the potential usefulness of a specific drug to prevent this by correcting the brain cell disorder.
A new imaging technique uncovers oxygen levels in prostate tumors and could lead to a non-invasive way to determine which tumors are more difficult to treat, according to a Cancer Research UK-funded study published in Theranostics.
OPKO Health, Inc. today announced the acquisition of an exclusive license from Arctic Partners Ab Oy for two biomarkers in the kallikrein family which, used together with prostate specific antigen (PSA), can reduce the need for prostate biopsies by over 50%.
Treating acute lymphocytic leukemia (ALL) can bring many challenges, particularly in the adult population. To optimally manage this disease in adult patients, healthcare professionals must understand and identify characteristics of high-risk disease, utilize best strategies for preventing central nervous system relapse, and recognize the important role of post-remission hematopoietic stem cell transplantation in ALL therapy.
Diabetes patients could benefit from new research at the University of Liverpool that has identified a molecule in the intestine that can 'taste' the sugar content of the diet.
› Verified 6 days ago
| Provider Name | Kalispell Regional Medical Center Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235333139 PECOS PAC ID: 5294644381 Enrollment ID: O20031122000142 |
News Archive
A new study published in the journal Nature Medicine on January 2020 suggests that Parkinson's disease developing before the age of 50 years could be due to an abnormality in certain brain cells that remains dormant until the age of onset of the disease. It also indicates the potential usefulness of a specific drug to prevent this by correcting the brain cell disorder.
A new imaging technique uncovers oxygen levels in prostate tumors and could lead to a non-invasive way to determine which tumors are more difficult to treat, according to a Cancer Research UK-funded study published in Theranostics.
OPKO Health, Inc. today announced the acquisition of an exclusive license from Arctic Partners Ab Oy for two biomarkers in the kallikrein family which, used together with prostate specific antigen (PSA), can reduce the need for prostate biopsies by over 50%.
Treating acute lymphocytic leukemia (ALL) can bring many challenges, particularly in the adult population. To optimally manage this disease in adult patients, healthcare professionals must understand and identify characteristics of high-risk disease, utilize best strategies for preventing central nervous system relapse, and recognize the important role of post-remission hematopoietic stem cell transplantation in ALL therapy.
Diabetes patients could benefit from new research at the University of Liverpool that has identified a molecule in the intestine that can 'taste' the sugar content of the diet.
› Verified 6 days ago
| Provider Name | Northwest Orthopedics And Sports Medicine Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1184679391 PECOS PAC ID: 1153336797 Enrollment ID: O20060217000413 |
News Archive
A new study published in the journal Nature Medicine on January 2020 suggests that Parkinson's disease developing before the age of 50 years could be due to an abnormality in certain brain cells that remains dormant until the age of onset of the disease. It also indicates the potential usefulness of a specific drug to prevent this by correcting the brain cell disorder.
A new imaging technique uncovers oxygen levels in prostate tumors and could lead to a non-invasive way to determine which tumors are more difficult to treat, according to a Cancer Research UK-funded study published in Theranostics.
OPKO Health, Inc. today announced the acquisition of an exclusive license from Arctic Partners Ab Oy for two biomarkers in the kallikrein family which, used together with prostate specific antigen (PSA), can reduce the need for prostate biopsies by over 50%.
Treating acute lymphocytic leukemia (ALL) can bring many challenges, particularly in the adult population. To optimally manage this disease in adult patients, healthcare professionals must understand and identify characteristics of high-risk disease, utilize best strategies for preventing central nervous system relapse, and recognize the important role of post-remission hematopoietic stem cell transplantation in ALL therapy.
Diabetes patients could benefit from new research at the University of Liverpool that has identified a molecule in the intestine that can 'taste' the sugar content of the diet.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa M Spors-murphy, OT Po Box 1456, Eureka, MT 59917-1456 Ph: (406) 297-3915 | Lisa M Spors-murphy, OT 298 Osloski Rd, Eureka, MT 59917-9058 Ph: (406) 297-3915 |
News Archive
A new study published in the journal Nature Medicine on January 2020 suggests that Parkinson's disease developing before the age of 50 years could be due to an abnormality in certain brain cells that remains dormant until the age of onset of the disease. It also indicates the potential usefulness of a specific drug to prevent this by correcting the brain cell disorder.
A new imaging technique uncovers oxygen levels in prostate tumors and could lead to a non-invasive way to determine which tumors are more difficult to treat, according to a Cancer Research UK-funded study published in Theranostics.
OPKO Health, Inc. today announced the acquisition of an exclusive license from Arctic Partners Ab Oy for two biomarkers in the kallikrein family which, used together with prostate specific antigen (PSA), can reduce the need for prostate biopsies by over 50%.
Treating acute lymphocytic leukemia (ALL) can bring many challenges, particularly in the adult population. To optimally manage this disease in adult patients, healthcare professionals must understand and identify characteristics of high-risk disease, utilize best strategies for preventing central nervous system relapse, and recognize the important role of post-remission hematopoietic stem cell transplantation in ALL therapy.
Diabetes patients could benefit from new research at the University of Liverpool that has identified a molecule in the intestine that can 'taste' the sugar content of the diet.
› Verified 6 days ago
Mrs. Donna Stafford, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 103 Mockingbird Ct, Eureka, MT 59917 Phone: 406-889-5759 | |
Caroline S. Sitkins, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1343 Us Highway 93 N, Eureka, MT 59917 Phone: 406-297-3915 |